Home | Cardiovascular Business

Devi Nair, MD, director of electrophysiology and research at St. Bernards Medical Center and the Arrhythmia Research Group, explains new technology advances in leadless pacing for conduction pacing and Bachmann's bundle pacing.

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.

Read more about Advances in leadless conduction and Bachmann’s bundle pacing next frontier in physiologic pacing

This novel vibration-based extraction technique exhibited excellent safety and efficiency profiles in preclinical and initial human study, potentially offering a simple, rapid, and safe alternative to conventional extraction methods

A novel vibration-based extraction technique appears to offer safety, efficiency and a simple, rapid, alternative to conventional lead removal.

Read more about Vibrations used to extract EP leads in first-in-human study

older patient with a doctor at their house

Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.

Read more about AFib patients with gout face greater stroke risk—but therapy can help

Cardiawave announced the first routine clinical use in Europe of its Valvosoft system since its CE mark regulator clearance in late 2025. It is a noninvasive, high-intensity ultrasound therapy to fragment leaflet calcium in severe symptomatic aortic stenosis, and I is aimed at patients who are not ideal for surgical or transcatheter aortic valve replacement, or who decline surgical intervention.

The Cardiawave Valvosoft system uses ultrasound imaging to direct a noninvasive, high-intensity ultrasound wave emitter to fragment leaflet calcium in severe symptomatic aortic stenosis.

The new technology was designed for patients who may not be able to undergo SAVR or TAVR.

Read more about High-intensity ultrasound technology for calcified valve leaflets makes debut in Europe

Cardiologist Michael McMullan explains his surprise about high levels of soft coronary plaque seen on CCTA despite years of intensive statin therapy. #YesCCT

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care.

Read more about CCTA scan at conference gives cardiologist a wake-up call

exercise aerobic training fitness resistance training older woman

Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.

Read more about Resistance training reduces heart attack risk in women

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness.

Read more about More than 11K bottles of blood pressure drug recalled

Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.

Read more about Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes

The Boston Scientific BodyGuardian Remote Monitoring System uses AI to help detect and monitor cardiac arrhythmias in ambulatory patients.

Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology.

Read more about Cardiology still one of the top specialties for FDA-cleared AI algorithms

Joshua R. Silverstein, MD, FHRS, a cardiac electrophysiologist at Allegheny Health Network Cardiovascular Institute, explains the real-world impacts of Centers of Medicare and Medicaid Services (CMS) RVU cuts in electrophysiology.

Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant.

Read more about 'Not sustainable': The real impact of RVU cuts in electrophysiology